TORONTO, June 30, 2021 (GLOBE NEWSWIRE) – Avicanna Inc. (the “Society” Where “Avicanna”) (TSX: AVCN) announced today that the Company’s audit is ongoing and that it plans to file the following periodic disclosure documents (collectively, the“ ”Documents”) In the next sixty to seventy-five days:
- annual audited financial statements for the year ended December 31, 2020;
- management’s discussion and analysis of the audited annual financial statements for the year ended December 31, 2020;
- annual information form for the fiscal year ended December 31, 2020;
- interim financial statements for the period ended March 31, 2021;
- CloseCurlyQuote’s management report and analysis; relating to the interim financial statements for the period ended March 31, 2021; and
- interim financial statements for the period ended June 30, 2021;
- management’s comments and analyzes relating to the interim financial statements for the period ended June 30, 2021; and
- certification of the above-mentioned filings, as required by NI 52-109 – Disclosure Certification in Issuers & CloseCurlyQuote; Annual and interim deposits.
The company continues to operate normally and is reaching operational milestones as described in the Company’s press release on June 24, 2021 available at the following link: https://www.globenewswire.com/news-release/2021/06 / 24 /2252975/0/en/Avicanna-Announces-Results-of-Annual-General-Meeting-and-Provides-Corporate-Update.html.
In accordance with the Company’s press release ‘on June 11, 2021, despite the cease trade order (‘Technical director”) Issued by the Ontario Securities Commission, a beneficial security holder of the Company who is not, and was not on the date of the CTO, an insider or control person of the Company, may sell securities of the Company acquired prior to the CTO date if the sale is made through an investment dealer registered in a jurisdiction of Canada on a “Foreign Organized Regulated Market & CloseCurlyDoubleQuote ;, as defined in section 1.1 of the Investment Industry Regulatory Organization of Canada Universal Market Integrity Rules. Holders of Avicanna securities are encouraged to consult their own investment advisers or legal advisers regarding the implications of OTC.
About Avicanna Inc.
Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development and commercialization of plant-derived cannabinoid products for the global consumer, medical and pharmaceutical market segments.
SOURCE Avicanna Inc.
For more information on Avicanna, visit www.avicanna.com, call 1-647-243-5283 or contact Setu Purohit, President by email at [email protected]
The Company posts updates via videos from the Company’s official YouTube channel https://www.youtube.com/channel/UC5yBclNIsNf7VrE34iwt8OA.
Please join the conversation about our supporter Avicanna ‘Telegram group at https://t.me/Avicannainc.
Caution regarding forward-looking information and statements
This press release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as “could”, “would”, “could”, “will”, “probably”, “expect”, “anticipate”, “Believe,” “intention”, “plan”, “forecast”, “project”, “estimate”, “prospect” and other similar expressions, and includes statements regarding the schedule for filing documents. Forward-looking information is not a guarantee of future performance and is based on a number of management’s estimates and assumptions in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions regarding future market conditions, the current and future regulatory environment and the availability of licenses, approvals and permits. Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on forward-looking information because the Company cannot guarantee that it will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to various risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. These risks and uncertainties include, without limitation, current and future market conditions, including the price of the Company’s common shares, and the risk factors set out in the Company’s annual information form dated April 15, 2020 and the final short version prospectus dated November 27, 2020, filed with the Canadian securities regulatory authorities and available under the Company’s profile on SEDAR at www.sedar.com. The statements contained in this press release are made as of the date of this press release. The Company disclaims any intention or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.